Axio Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.71 Cr
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.84 Cr
- Satisfied Charges ₹ 2.42 Cr
- Revenue Growth 38.38%
- Profit Growth -40.34%
- Ebitda -51.11%
- Net Worth 194.01%
- Total Assets 58.72%
About Axio Biosolutions
Axio Biosolutions Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 May 2008 and has a history of 16 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.71 Cr.
The company currently has active open charges totaling ₹7.84 Cr. The company has closed loans amounting to ₹2.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Leo Mavely and Gourav Maheshwari serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100GJ2008PTC053905
-
Company No.
053905
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 May 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Axio Biosolutions Private Limited offer?
Axio Biosolutions Private Limited offers a wide range of products and services, including Hospital Dressings, Adhesive Wound Dressing, Cleaning Liquids & Wipes, Disinfectant Spray, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Industrial Chemicals & Supplies, Colloidal Silver, Bandages & Dressing Disposables, Forceps & Graspers.
Who are the key members and board of directors at Axio Biosolutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gourav Maheshwari
|
Director | 16-May-2018 | Current |
|
Leo Mavely
|
Director | 16-May-2008 | Current |
Financial Performance of Axio Biosolutions.
Axio Biosolutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.38% increase. The company also saw a substantial fall in profitability, with a 40.34% decrease in profit. The company's net worth Soared by an impressive increase of 194.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axio Biosolutions?
In 2022, Axio Biosolutions had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Leyam Enterprises LlpLeo Mavely is a mutual person
Charges (Loans)
₹7.84 Cr
₹2.42 Cr
Charges Breakdown by Lending Institutions
- Others : 7.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2023 | Others | ₹7.84 Cr | Open |
| 18 Oct 2013 | Technology Development Board | ₹1.33 Cr | Satisfied |
| 28 Jun 2010 | Gvfl Trustee Company Private Limited | ₹1.09 Cr | Satisfied |
How Many Employees Work at Axio Biosolutions?
Axio Biosolutions has a workforce of 106 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axio Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axio Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
